Evaluation of the Impact of Mobile Health App Vitadio in Patients With Type 2 Diabetes: Randomized Controlled Trial
Open accessPublished version of a preprint
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index; 24 of the 37 sources its claims cite were checked for support.
Abstract
Background: Effective diabetes management requires a multimodal approach involving lifestyle changes, pharmacological treatment, and continuous patient education. Self-management demands can be overwhelming for patients, leading to lowered motivation, poor adherence, and compromised therapeutic outcomes. In this context, digital health apps are emerging as vital tools to provide personalized support and enhance diabetes management and clinical outcomes. Objective: This study evaluated the impact of the digital health application Vitadio on glycemic control in patients with type 2 diabetes mellitus (T2DM). Secondary objectives included evaluating its effects on cardiometabolic parameters (weight, BMI, waist circumference, blood pressure, and heart rate) and self-reported measures of diabetes distress and self-management. Methods: In this 6-month, 2-arm, multicenter, unblinded randomized controlled trial, patients aged 18 years or older diagnosed with T2DM were randomly assigned (1:1) to an intervention group (IG) receiving standard diabetes care reinforced by the digital health app Vitadio or to a control group (CG) provided solely with standard diabetes care. Vitadio provided a mobile-based self-management support tool featuring educational modules, motivational messages, peer support, personalized goal setting, and health monitoring. The personal consultant was available in the app to provide technical support for app-related issues. The primary outcome, assessed in the intention-to-treat population, was a change in glycated hemoglobin (HbA1c) levels at 6 months. Secondary outcomes included changes in cardiometabolic measures and self-reported outcomes. Data were collected in 2 study centers: diabetologist practice in Dessau-Roßlau and the University of Dresden. Results: Between November 2022 and June 2023, a total of 276 patients were screened for eligibility, with 149 randomized to in intervention group (IG; n=73) and a control group (CG; n=76). The majority of participants were male (91/149, 61%). The dropout rate at month 6 was 19% (121/149). While both groups achieved significant HbA1c reduction at 6 months (IG: mean –0.8, SD 0.9%, P<.001; CG: mean –0.3, SD 0.7%, P=.001), the primary confirmatory analysis revealed statistically significant advantage of the IG (adjusted mean difference: –0.53%, SD 0.15, 95% CI –0.24 to –0.82; P<.001; effect size [Cohen d]=0.67, 95% CI 0.33-1). Significant between-group differences in favor of the IG were also observed for weight loss (P=.002), BMI (P=.001) and systolic blood pressure (P<.03). In addition, Vitadio users experienced greater reduction in diabetes-related distress (P<.03) and obtained more pronounced improvements in self-care practices in the areas of general diet (P<.001), specific diet (P<.03), and exercise (P<.03). Conclusions: This trial provides evidence for the superior efficacy of Vitadio in lowering the HbA1c levels in T2DM patients compared to standard care. In addition, Vitadio contributed to improvements in cardiometabolic health, reduced diabetes-related distress, and enhanced self-management, highlighting its potential as an accessible digital tool for comprehensive diabetes management. Trial Registration: German Clinical Trials Registry DRKS00027405; https://drks.de/search/de/trial/DRKS00027405.
Overview
CoChat Summary
TL;DR
In a 6-month, 2-arm, multicenter, unblinded randomized controlled trial, adding the Vitadio mobile health app to standard diabetes care significantly improved glycemic control in adults with type 2 diabetes compared with standard care alone. Vitadio users also showed greater improvements in several cardiometabolic and self-reported outcomes, including weight, BMI, systolic blood pressure, diabetes distress, and self-management.
Key findings
- The primary outcome favored Vitadio: adjusted mean HbA1c difference at 6 months was –0.53% (SD 0.15, 95% CI –0.24 to –0.82; P<.001; Cohen d=0.67, 95% CI 0.33-1). Mean HbA1c reduction was –0.8% (SD 0.9; P<.001) in the intervention group vs –0.3% (SD 0.7; P=.001) in the control group.
- Responder analysis showed more intervention participants reached HbA1c ≤7.0% (26% vs 8%; P=.004; OR 4.05, 95% CI 1.51-10.83), HbA1c ≤6.5% (11% vs 0%; P=.003; OR 19.6, 95% CI 1.11-346.06), and a ≥0.3% HbA1c reduction (77% vs 52%; P=.002; OR 3.04, 95% CI 1.5-6.17).
- Significant between-group differences favoring Vitadio were reported for weight (MD –1.33 kg, 95% CI –2.25 to –0.42; P=.002), BMI (MD –0.47 kg/m², 95% CI –0.77 to –0.16; P=.001), systolic blood pressure (MD –7.8 mm Hg, 95% CI –13.45 to –2.16; P=.004), diabetes-related distress (PAID MD –6.21, 95% CI –10.58 to –1.85; P=.003), and SDSCA general diet (P<.001), specific diet (P=.007), and exercise (P=.02).
- Vitadio was rated positively on most User Experience Questionnaire scales, with highest perspicuity (mean 1.42, SD 1.06); app-generated data showed average use on 95 (SD 63) days, 81% (35/43) completed all core education materials, and 81% (35/43) logged meals.
Methods
- Design: 6-month, 2-arm, multicenter, unblinded randomized controlled trial; adults aged ≥18 years with T2DM and baseline HbA1c ≥7.5% to ≤11% were randomized 1:1 to Vitadio plus standard diabetes care or standard care alone.
- Sample: 276 screened, 149 randomized (intervention n=73; control n=76); mean age 60.6 (SD 10.8) years, mean diabetes duration 11.7 (SD 7.5) years, 61% male; dropout at month 6 was reported as 19% (121/149).
- Analysis: primary confirmatory analysis used intention-to-treat with a linear mixed-effects model for HbA1c over 3 visits, controlling for age, sex, insulin treatment, and diabetes duration; missing data imputed using reference-based multiple imputation; per-protocol and responder analyses also reported.
Limitations
- Stated: blinding of participants and study physicians was not feasible due to the intervention’s nature; expectation bias in patient-reported outcomes cannot be fully excluded, though objective laboratory primary outcomes were considered unlikely to be affected.
- Stated: attrition rates differed between study arms; imputation methods were used to minimize bias.
- Evident from the text: the trial was conducted at two German study centers over 6 months, the sample was predominantly male (91/149, 61%), and longer-term durability beyond 6 months was not assessed.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
11 Valid · 2 Not valid · 7 Not checked · 90 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Assuming an effect size of 0.55, a significance level of 2.5% (1-sided test), and a power of 0.8, a sample size of 69 participants per group, that is, at least 138 participants in total, was required to demonstrate a significant effect. This included an expected attrition rate of 23% [37].”
§ Evaluation of the Impact of Mobile Health App Vitadio in Patients With Type 2 Diabetes: Randomized Controlled Trial > Methods > Statistical Analysis
What the sources say
- Disputedcites [37] sourceExperimental — accuracy not yet measured
The citation is attached to the expected 23% attrition rate, not the preceding sample-size calculation. The Results > Meta-Analysis passage reports 43% attrition overall and 40% in randomized trials, rather than 23%. The paper does not provide the cited 23% estimate. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
plainn = 138- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The lack of adherence to behavioral changes represents an important challenge in diabetes management, identified as the most significant modifiable factor compromising therapeutic outcomes [20,21].”
§ Evaluation of the Impact of Mobile Health App Vitadio in Patients With Type 2 Diabetes: Randomized Controlled Trial > Introduction
What the sources say
- Partly supportedcites [20] sourceExperimental — accuracy not yet measured
The Discussion (Principal Findings; page unavailable) treats adherence as important to successful chronic disease management, and the Results (Study Outcomes and Indicators; page unavailable) include healthy behaviors among the adherence measures. The paper does not identify failure to sustain behavioral changes as the most significant modifiable factor compromising therapeutic outcomes specifically in diabetes. (LLM, conf=0.82)
- Partly supportedcites [21] sourceExperimental — accuracy not yet measured
The Introduction (page not provided in our copy) calls adherence to treatment the most important modifiable factor compromising treatment outcomes and says adherence includes behavioral changes, which are a major challenge in treating noncommunicable diseases. It does not identify lack of adherence to behavioral changes specifically as the most significant factor in diabetes management. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This finding is clinically important, as high levels of diabetes distress are known to negatively affect self-care behaviors, medication adherence, and glycemic control [40-42].”
§ Evaluation of the Impact of Mobile Health App Vitadio in Patients With Type 2 Diabetes: Randomized Controlled Trial > Discussion > Principal Findings
What the sources say
- Not checked — no full text of the sourcecites [40] source
- Partly supportedcites [41] sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) reports research associating diabetes-related distress with problematic self-care and glycemic control, and the Abstract identifies medication adherence as part of the self-care measure. But the paper calls the literature inconclusive and finds that diabetes distress has no independent association with self-care after accounting for general psychological distress. These associations do not establish that high diabetes distress itself negatively affects all three outcomes. (LLM, conf=0.86)
- Supportedcites [42] source
The Conclusion states that diabetes distress can reduce HbA1c control and treatment adherence in people with type 2 diabetes. The section on diabetes management and self-care associates high psychological distress with poorer self-care, while the Abstract links diabetes distress to poor disease management. Together, these support the citing sentence’s broad claim. (LLM, conf=0.87)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While DSME has consistently been demonstrated to improve patients’ clinical [15] and psychosocial [16] outcomes, many DSME participants report that the program did not fully meet their information and support needs [14].”
§ Evaluation of the Impact of Mobile Health App Vitadio in Patients With Type 2 Diabetes: Randomized Controlled Trial > Introduction
What the sources say
- Supportedcites [15] source
Citation [15] is attached to “clinical,” while a separate citation supports “psychosocial.” The Discussion (§4.1) reports that DSME was associated with significant improvements in glycemic control, a clinical outcome, although not every intervention showed a significant improvement. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [16] source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“81% (35/43) of them completed all core education materials”
§ Evaluation of the Impact of Mobile Health App Vitadio in Patients With Type 2 Diabetes: Randomized Controlled Trial > Results > Secondary Outcomes
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
64 more claims
Create a free account to see all 110 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 30
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“77%, 56/73 compared to 52%, 41/76 in CG”
§ Evaluation of the Impact of Mobile Health App Vitadio in Patients With Type 2 Diabetes: Randomized Controlled Trial > Results > Primary Outcomes
Reported 52 · recomputed 53.947368
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“The dropout rate at month 6 was 19% (121/149).”
§ Evaluation of the Impact of Mobile Health App Vitadio in Patients With Type 2 Diabetes: Randomized Controlled Trial > Abstract > Results
Reported 19 · recomputed 81.208054
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Evaluation of the Impact of Mobile Health App Vitadio in Patients With Type 2 Diabetes: Randomized Controlled Trial > Results > Participants Characteristics
“Each group comprised slightly more men (IG: 67%, CG: 57%) than women.”
§ Evaluation of the Impact of Mobile Health App Vitadio in Patients With Type 2 Diabetes: Randomized Controlled Trial > Results > Participants Characteristics
“| Male, n (%) | Male, n (%) | 91 (61) | 49 (67) | 42 (55) | .18 |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Evaluation of the Impact of Mobile Health App Vitadio in Patients With Type 2 Diabetes: Randomized Controlled Trial > Results > Primary Outcomes
“22.2% (12/54) of patients in the CG required an increase in their medication dosage.”
§ Evaluation of the Impact of Mobile Health App Vitadio in Patients With Type 2 Diabetes: Randomized Controlled Trial > Results > Participants Characteristics
“In total, 124 (IG: n=69, CG: n=55) and 121 (IG: n=70, CG: n=51) participants attended the 3- and 6-month follow-ups, respectively.”
Citations
Cites
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) · Behavior Research Methods · doi:10.3758/bf03193146 · Cited by 65,971 · cited 1×
“The sample size calculation was performed with the program G*Power [36] and assumed a difference in HbA 1c reduction of 0.5% and an HbA 1c SD of 0.8% for the CG and 1.0% for the IG.”
Influential2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755 · cited 1×
“It is estimated that a 10-mm Hg reduction in systolic blood pressure lowers the risk of developing major cardiovascular events by 20%, coronary heart disease by 17%, stroke by 27%, heart failure by 28%, and all-cause mortality by 13% [39].”
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518 · cited 2×
“The treatment goals were selected based on the international consensus guidelines for the management of diabetes mellitus [4,27].”
The summary of diabetes self-care activities measure: results from 7 studies and a revised scale.
Toobert, D. J., Hampson, S. E., & Glasgow, R. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.943 · Cited by 2,561 · cited 2×
“Patients scoring 40 or higher may be at the level of “emotional burnout” and warrant special attention [33,34].”
Body Fat Distribution and Risk of Cardiovascular Disease: An Update
Després, J.-P. (2012) · Circulation · doi:10.1161/circulationaha.111.067264 · Cited by 1,481 · cited 1×
“Moreover, considering the cardiovascular risks associated with high resting heart rate (>75-80 bpm) [30,31] and abdominal obesity [32], proxy measures of fat mass, for example, BMI and waist circumference, along with heart rate were collected.”
Hamine, S., Gerth-Guyette, E., Faulx, D., Green, B. B., & Ginsburg, A. S. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.3951 · Cited by 1,149 · cited 2×
“The lack of adherence to behavioral changes represents an important challenge in diabetes management, identified as the most significant modifiable factor compromising therapeutic outcomes [20,21].”
Peyrot, M., Rubin, R. R., Lauritzen, T., Snoek, F. J., Matthews, D. R., & Skovlund, S. E. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01644.x · Cited by 931
Chrvala, C. A., Sherr, D., & Lipman, R. D. (2016) · Patient Education and Counseling · doi:10.1016/j.pec.2015.11.003 · Cited by 914 · cited 1×
“While DSME has consistently been demonstrated to improve patients’ clinical [15] and psychosocial [16] outcomes, many DSME participants report that the program did not fully meet their information and support needs [14].”
6. Glycemic Targets: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s006 · Cited by 847
Meyerowitz-Katz, G., Ravi, S., Arnolda, L., Feng, X., Maberly, G., & Astell-Burt, T. (2020) · Journal of Medical Internet Research · doi:10.2196/20283 · Cited by 561 · cited 1×
“This included an expected attrition rate of 23% [37].”
Perrin, N. E., Davies, M. J., Robertson, N., Snoek, F. J., & Khunti, K. (2017) · Diabetic Medicine · doi:10.1111/dme.13448 · Cited by 495 · cited 1×
“Adopting new healthier habits, along with the need for constant blood glucose monitoring and medication adherence, often leads to increased emotional distress and feelings of being overwhelmed [6,11-13].”
Constructs of depression and distress in diabetes: time for an appraisal
Snoek, F. J., Bremmer, M. A., & Hermanns, N. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00135-7 · Cited by 449 · cited 1×
“Patients scoring 40 or higher may be at the level of “emotional burnout” and warrant special attention [33,34].”
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s005 · Cited by 445 · cited 1×
“This finding is clinically important, as high levels of diabetes distress are known to negatively affect self-care behaviors, medication adherence, and glycemic control [40-42].”
Diabetes structured self-management education programmes: a narrative review and current innovations
Chatterjee, S., Davies, M. J., Heller, S., Speight, J., Snoek, F. J., & Khunti, K. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30239-5 · Cited by 372 · cited 1×
“While DSME has consistently been demonstrated to improve patients’ clinical [15] and psychosocial [16] outcomes, many DSME participants report that the program did not fully meet their information and support needs [14].”
Powers, M. A., Bardsley, J., Cypress, M., Duker, P., Funnell, M. M., Fischl, A. H., Maryniuk, M. D., Siminerio, L., & Vivian, E. (2016) · Clinical Diabetes · doi:10.2337/diaclin.34.2.70 · Cited by 285
Lifestyle factors, self-management and patient empowerment in diabetes care
Lambrinou, E., Hansen, T. B., & Beulens, J. W. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319885455 · Cited by 261 · cited 1×
“In addition, it requires substantial diabetes-related knowledge and health literacy, enabling patients to make well-informed decisions about their lifestyle choices [8,14].”
Cotter, A. P., Durant, N., Agne, A. A., & Cherrington, A. L. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.07.003 · Cited by 239
Lunde, P., Nilsson, B. B., Bergland, A., Kværner, K. J., & Bye, A. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.9751 · Cited by 214 · cited 1×
“The lack of adherence to behavioral changes represents an important challenge in diabetes management, identified as the most significant modifiable factor compromising therapeutic outcomes [20,21].”
The importance of addressing depression and diabetes distress in adults with type 2 diabetes
Owens-Gary, M. D., Zhang, X., Jawanda, S., Bullard, K. M., Allweiss, P., & Smith, B. D. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4705-2 · Cited by 194
SCHMITT, A. J., Reimer, A., Kulzer, B., Haak, T., Ehrmann, D., & Hermanns, N. (2015) · Diabetic Medicine · doi:10.1111/dme.12887 · Cited by 175
Interventions for self-management of type 2 diabetes: An integrative review
Carpenter, R., DiChiacchio, T., & Barker, K. (2019) · International Journal of Nursing Sciences · doi:10.1016/j.ijnss.2018.12.002 · Cited by 170 · cited 2×
“Adopting new healthier habits, along with the need for constant blood glucose monitoring and medication adherence, often leads to increased emotional distress and feelings of being overwhelmed [6,11-13].”
Sönnichsen, A. C., Winkler, H., Flamm, M., Panisch, S., Kowatsch, P., Klima, G., Fürthauer, B., & Weitgasser, R. (2010) · BMC Family Practice · doi:10.1186/1471-2296-11-86 · Cited by 141 · cited 1×
“Similarly, the disease management program for type 2 diabetes patients, launched in Germany in 2002, despite its positive impact on quality of care [17-19], does not guarantee patients’ active involvement in the disease management in-between medical check-ups.”
Thoolen, B. J., Ridder, D. D., Bensing, J., Gorter, K., & Rutten, G. (2009) · Psychology & Health · doi:10.1080/08870440701864504 · Cited by 127 · cited 1×
“Adopting new healthier habits, along with the need for constant blood glucose monitoring and medication adherence, often leads to increased emotional distress and feelings of being overwhelmed [6,11-13].”
Non-pharmacological Treatment Options in the Management of Diabetes Mellitus
Raveendran, A. V. (2018) · European Endocrinology · doi:10.17925/ee.2018.14.2.31 · Cited by 122
Hermanns, N., Ehrmann, D., Finke‐Groene, K., & Kulzer, B. (2020) · Diabetic Medicine · doi:10.1111/dme.14256 · Cited by 117 · cited 1×
“…real-time support and educational resources, along with tailored feedback and easily accessible reports on glycemic control, mobile health solutions can support patients’ adherence to treatment, improve their self-management, and as a consequence, contribute to better health outcomes [20,22].”
Disease Management Programs for Type 2 Diabetes in Germany
Fuchs, S., Henschke, C., Blümel, M., & Busse, R. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0453 · Cited by 102 · cited 1×
“Similarly, the disease management program for type 2 diabetes patients, launched in Germany in 2002, despite its positive impact on quality of care [17-19], does not guarantee patients’ active involvement in the disease management in-between medical check-ups.”
Cro, S., Morris, T. P., Kenward, M. G., & Carpenter, J. R. (2016) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x1601600211 · Cited by 67 · cited 1×
“Missing data were imputed using the “Randomized Arm missing at randommar” [38] approach using the RefBasedMI R library.”
Landgraf, R., Aberle, J., Birkenfeld, A. L., Gallwitz, B., Kellerer, M., Klein, H., Müller-Wieland, D., Nauck, M. A., Reuter, H.-M., & Siegel, E. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1018-9106 · Cited by 62
Böhm, M., Schumacher, H., Teo, K. K., Lonn, E. M., Mahfoud, F., Ukena, C., Mann, J. F. E., Mancia, G., Redon, J., Schmieder, R. E., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehy808 · Cited by 55 · cited 1×
“Moreover, considering the cardiovascular risks associated with high resting heart rate (>75-80 bpm) [30,31] and abdominal obesity [32], proxy measures of fat mass, for example, BMI and waist circumference, along with heart rate were collected.”
Impact of a Digital Lifestyle Intervention on Diabetes Self-Management: A Pilot Study
Bretschneider, M. P., Klásek, J., Karbanová, M., Timpel, P., Herrmann, S., & Schwarz, P. E. H. (2022) · Nutrients · doi:10.3390/nu14091810 · Cited by 39 · cited 2×
“This assumption is based on the previous results of the Czech randomized controlled trial in patients with obesity [24] and a German observational study in patients with T2DM [25].”
Self-citationMoravcová, K., Karbanová, M., Bretschneider, M. P., Sovová, M., Ožana, J., & Sovová, E. (2022) · Nutrients · doi:10.3390/nu14102005 · Cited by 37 · cited 3×
“This assumption is based on the previous results of the Czech randomized controlled trial in patients with obesity [24] and a German observational study in patients with T2DM [25].”
Self-citationDistress and Type 2 Diabetes Self-Care: Putting the Pieces Together
Hoogendoorn, C. J., Schechter, C. B., Llabre, M. M., Walker, E. A., & Gonzalez, J. S. (2021) · Annals of Behavioral Medicine · doi:10.1093/abm/kaaa070 · Cited by 28
Mehring, M., Donnachie, E., Bonke, F. C., Werner, C., & Schneider, A. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0236-y · Cited by 26
Jacobs, E., & Rathmann, W. (2017) · Diabetologie und Stoffwechsel · doi:10.1055/s-0043-120034 · Cited by 25 · cited 1×
“Over 9.1 million adults in Germany have been diagnosed with type 2 diabetes mellitus (T2DM), and around 500,000 new cases of the disease occur in the German population every year [1,2].”
InfluentialMultidisciplinary Approach to Management and Care of Patients with Type 2 Diabetes Mellitus
Bain, S., Cummings, M. H., & McKay, G. A. (2019) · EMJ Diabetes · doi:10.33590/emjdiabet/10314374 · Cited by 22 · cited 1×
“Adequate management of diabetes is highly complex and challenging, necessitating a multimodal therapeutic approach to effectively control the condition and prevent associated microvascular and cardiovascular complications [3-5].”
Health Internet Technology for Chronic Conditions: Review of Diabetes Management Apps
Sneha, S., Thalla, S., Rischie, I., & Shahriar, H. (2021) · JMIR Diabetes · doi:10.2196/17431 · Cited by 20 · cited 1×
“Given that diabetes is directly influenced by various lifestyle factors, lifestyle modifications, including dietary changes, weight management, increased physical activity, smoking cessation, and psychological support, are the cornerstones of nonpharmacological management of the condition [4,6-10].”
Spatio-temporal trends in the incidence of type 2 diabetes in Germany
Tönnies, T., Hoyer, A., Brinks, R., Kuss, O., Hering, R., & Schulz, M. (2023) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2022.0405 · Cited by 19 · cited 1×
“Over 9.1 million adults in Germany have been diagnosed with type 2 diabetes mellitus (T2DM), and around 500,000 new cases of the disease occur in the German population every year [1,2].”
InfluentialHeise, M., Heidemann, C., Baumert, J., Du, Y., Frese, T., Avetisyan, M., & Weise, S. (2022) · Primary Care Diabetes · doi:10.1016/j.pcd.2022.03.016 · Cited by 15 · cited 2×
“In addition, it requires substantial diabetes-related knowledge and health literacy, enabling patients to make well-informed decisions about their lifestyle choices [8,14].”
Landgraf, R., Aberle, J., Birkenfeld, A. L., Gallwitz, B., Kellerer, M., Klein, H., Müller-Wieland, D., Nauck, M. A., Wiesner, T., & Siegel, E. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1624-3449 · Cited by 12 · cited 3×
“Orientation parameters for therapeutic goals have been established for weight loss (for BMI from 27-35 kg/m 2 : >5% weight reduction; for BMI >35 kg/m 2 : >10% weight reduction), systolic blood pressure (120-140 mm Hg), and diastolic blood pressure (<80 mm Hg; not <70 mm Hg) [28,29].”
Kamimura, D., & Tamura, K. (2023) · Hypertension Research · doi:10.1038/s41440-023-01251-9 · Cited by 5 · cited 1×
“Moreover, considering the cardiovascular risks associated with high resting heart rate (>75-80 bpm) [30,31] and abdominal obesity [32], proxy measures of fat mass, for example, BMI and waist circumference, along with heart rate were collected.”
Schikora, S. (2017) · Diabetes aktuell · doi:10.1055/s-0043-111050 · Cited by 1
Cited by
Morelli, S., & Giansanti, D. (2025) · Bioengineering · doi:10.3390/bioengineering13010054 · Cited by 12
af Geijerstam, P., Johansson, E., Fägerstam, S., Wu, J. H. Y., Ghafouri, B., Karlsson, K., Hebib, L., Kastbom, L., Wennberg, P., Hedov, E. G., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-110141 · Cited by 1
Roth, L., Bretschneider, M. P., & Schwarz, P. E. H. (2025) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1644612 · Cited by 2
Self-citationThe role of self-management in the rehabilitation of type 2 diabetes patients
Kryukova, I. V. (2026) · Реабилитология. · doi:10.17749/2949-5873/rehabil.2025.54
Digitale Gesundheitsanwendungen: Ein neuer Ansatz im Management von Komorbiditäten
Bartsch, V., & Knitza, J. (2025) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-025-01743-8
Metadata
- Authors
- Bretschneider, M. P., Kolasińska, A. B., Šomvárska, L., Klásek, J., Mareš, J., & Schwarz, P. E.
- Affiliations
- Technische Universität Dresden (DE)
- Vidia (Czechia) (CZ)
- German Center for Diabetes Research (DE)
- Corresponding author
- Bretschneider, Maxi Pia
- ORCID
- Venue
- Journal of Medical Internet Research
- Publisher
- JMIR Publications Inc.
- Published
- 2025-05-09
- Volume
- 27
- Pages
- e68648
- ISSN
- 1438-8871 (ISSN-L)
- PMC
- PMC12102620
- OpenAlex
- W4410224886
- Cited by
- 23
- References
- 40
- Citations by year
- 2026: 15 · 2025: 8
- FWCI
- 17.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Medical Internet Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Bundesinstitut für Arzneimittel und Medizinprodukte
- Topics
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, mobile health apps, glycemic control, HbA1c, diabetes self-management, diabetes distress, cardiometabolic parameters, peer support, goal setting, digital health interventions, patient education, medication adherence, blood pressure, waist circumference, body mass index, heart rate monitoring, remote patient monitoring
- MeSH terms
- Self-Management, Adult, Aged, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Male, Middle Aged, Self Care, Telemedicine, Mobile Applications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.